Data / Form D filings / Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc.: Form D filings
Ajax Therapeutics, Inc., a biotechnology company in New York, NY, filed 3 Form D notices with the SEC between 2019 and 2024. The latest, on May 13, 2024, reports $95 million sold of a $95 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 275 MADISON AVE, 39TH FLOOR, New York, NY, 10016
- Phone
- (917) 410-7250
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1780490
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2024 | New notice | $95,000,000 | $95,000,000 | 21 | Apr 26, 2024 | sec.gov | |
| Jun 1, 2021 | New notice | $40,000,000 | $37,382,554 | $2,617,446 | 14 | May 17, 2021 | sec.gov |
| Jun 28, 2019 | New notice | $8,000,000 | $8,000,000 | 6 | Jun 12, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Martin Vogelbaum | Executive Officer, Director | |
| Ross Levine | Director | |
| Scott Platshon | Director | |
| Ramy Farid | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of May 13, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ajax Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.